China’s blood product market size is about 24 billion Yuan, HSA dominates but factor VIII was 6.3 %

The Chinese blood market, with liberalized price control, grew by 16.7 % from 2015 to 2016. It is served by 28 companies which operate about 200 collection stations. There are 11 types of blood products of which human serum albumin is 54 %, human immunoglobulins 24 %. Factor VIII accounted for 6.3 % of blood products in 2016. Many more details are provided in the article.

China Bio news release, December 28, 2017

China’s blood product market size is about 24 billion Yuan, HSA dominates but factor VIII was 6.3 %
Scroll to top